Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Chris Rathbun

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Evidence-Based Medicine|November 17, 2012
HIV consensus guideline recommends antiretroviral treatment regardless of CD4 count, new regimens and possible regimen change for chronic low level viraemiaR Chris Rathbun
Expert Opinion on Investigational Drugs|February 28, 2002
Review of the safety and efficacy of voriconazoleHolly L Hoffman, R Chris Rathbun
Expert Opinion on Drug Safety|January 26, 2010
Drug interactions with antiretrovirals and warfarinMichelle D Liedtke, R Chris Rathbun
Pharmaceutics|December 7, 2013
Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for managementR Chris Rathbun, Michelle D Liedtke
The Annals of Pharmacotherapy|March 29, 2002
Low-dose ritonavir for protease inhibitor pharmacokinetic enhancementR Chris Rathbun, Deanna R Rossi
The Annals of Pharmacotherapy|February 7, 2009
Warfarin-antiretroviral interactionsMichelle D Liedtke, R Chris Rathbun
The Annals of Pharmacotherapy|November 2, 2012
A probable interaction between warfarin and the antiretroviral TRIO study regimenMichelle D Liedtke, Amulya Vanguri, R Chris Rathbun
Pharmacotherapy|October 23, 2002
Symptomatic orthostasis with extended-release nifedipine and protease inhibitorsDeanna R Rossi, R Chris Rathbun, Leonard N Slater
The Annals of Pharmacotherapy|February 19, 2004
Anticonvulsant and antiretroviral interactionsMichelle D Liedtke, Staci M Lockhart, R Chris Rathbun
Expert Review of Anti-Infective Therapy|October 16, 2004
Review of antiviral therapy for herpes labialis, genital herpes and herpes zosterMichelle D Moomaw, Paul Cornea, R Chris Rathbun, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Evidence-Based Medicine|November 17, 2012
HIV consensus guideline recommends antiretroviral treatment regardless of CD4 count, new regimens and possible regimen change for chronic low level viraemiaR Chris Rathbun
Expert Opinion on Investigational Drugs|February 28, 2002
Review of the safety and efficacy of voriconazoleHolly L Hoffman, R Chris Rathbun
Expert Opinion on Drug Safety|January 26, 2010
Drug interactions with antiretrovirals and warfarinMichelle D Liedtke, R Chris Rathbun
Pharmaceutics|December 7, 2013
Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for managementR Chris Rathbun, Michelle D Liedtke
The Annals of Pharmacotherapy|March 29, 2002
Low-dose ritonavir for protease inhibitor pharmacokinetic enhancementR Chris Rathbun, Deanna R Rossi
The Annals of Pharmacotherapy|February 7, 2009
Warfarin-antiretroviral interactionsMichelle D Liedtke, R Chris Rathbun
The Annals of Pharmacotherapy|November 2, 2012
A probable interaction between warfarin and the antiretroviral TRIO study regimenMichelle D Liedtke, Amulya Vanguri, R Chris Rathbun
Pharmacotherapy|October 23, 2002
Symptomatic orthostasis with extended-release nifedipine and protease inhibitorsDeanna R Rossi, R Chris Rathbun, Leonard N Slater
The Annals of Pharmacotherapy|February 19, 2004
Anticonvulsant and antiretroviral interactionsMichelle D Liedtke, Staci M Lockhart, R Chris Rathbun
Expert Review of Anti-Infective Therapy|October 16, 2004
Review of antiviral therapy for herpes labialis, genital herpes and herpes zosterMichelle D Moomaw, Paul Cornea, R Chris Rathbun, et al.
Pageof 3